BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 21544018)

  • 1. Association between adverse effects under azathioprine therapy and inosine triphosphate pyrophosphatase activity in patients with chronic inflammatory bowel disease.
    Shipkova M; Franz J; Abe M; Klett C; Wieland E; Andus T
    Ther Drug Monit; 2011 Jun; 33(3):321-8. PubMed ID: 21544018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inosine triphosphate pyrophosphatase and thiopurine s-methyltransferase genotypes relationship to azathioprine-induced myelosuppression.
    Zelinkova Z; Derijks LJ; Stokkers PC; Vogels EW; van Kampen AH; Curvers WL; Cohn D; van Deventer SJ; Hommes DW
    Clin Gastroenterol Hepatol; 2006 Jan; 4(1):44-9. PubMed ID: 16431304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse drug reactions to azathioprine therapy are associated with polymorphism in the gene encoding inosine triphosphate pyrophosphatase (ITPase).
    Marinaki AM; Ansari A; Duley JA; Arenas M; Sumi S; Lewis CM; Shobowale-Bakre el-M; Escuredo E; Fairbanks LD; Sanderson JD
    Pharmacogenetics; 2004 Mar; 14(3):181-7. PubMed ID: 15167706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between inosine triphosphate pyrophosphohydrolase deficiency and azathioprine-related adverse drug reactions in the Chinese kidney transplant recipients.
    Xiong H; Xin HW; Wu XC; Li Q; Xiong L; Yu AR
    Fundam Clin Pharmacol; 2010 Jun; 24(3):393-400. PubMed ID: 19682085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TPMT and ITPA genetic variants in Lithuanian inflammatory bowel disease patients: Prevalence and azathioprine-related side effects.
    Steponaitiene R; Kupcinskas J; Survilaite S; Varkalaite G; Jonaitis L; Kiudelis G; Denapiene G; Valantinas J; Skieceviciene J; Kupcinskas L
    Adv Med Sci; 2016 Mar; 61(1):135-40. PubMed ID: 26674571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of ITPA phenotype-genotype correlation in the Bulgarian population revealed a novel gene variant in exon 6.
    Atanasova S; Shipkova M; Svinarov D; Mladenova A; Genova M; Wieland E; Oellerich M; von Ahsen N
    Ther Drug Monit; 2007 Feb; 29(1):6-10. PubMed ID: 17304144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement of erythrocyte inosine triphosphate pyrophosphohydrolase (ITPA) activity by HPLC and correlation of ITPA genotype-phenotype in a Caucasian population.
    Shipkova M; Lorenz K; Oellerich M; Wieland E; von Ahsen N
    Clin Chem; 2006 Feb; 52(2):240-7. PubMed ID: 16384889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of association between the ITPA 94C>A polymorphism and adverse effects from azathioprine.
    Gearry RB; Roberts RL; Barclay ML; Kennedy MA
    Pharmacogenetics; 2004 Nov; 14(11):779-81. PubMed ID: 15564886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation in the ITPA gene predicts intolerance to azathioprine.
    Marinaki AM; Duley JA; Arenas M; Ansari A; Sumi S; Lewis CM; Shobowale-Bakre M; Fairbanks LD; Sanderson J
    Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1393-7. PubMed ID: 15571265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pharmacogenetics study of TPMT and ITPA genes detects a relationship with side effects and clinical response in patients with inflammatory bowel disease receiving Azathioprine.
    Zabala-Fernández W; Barreiro-de Acosta M; Echarri A; Carpio D; Lorenzo A; Castro J; Martínez-Ares D; Pereira S; Martin-Granizo I; Corton M; Carracedo A; Barros F
    J Gastrointestin Liver Dis; 2011 Sep; 20(3):247-53. PubMed ID: 21961091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenetics of thiopurine therapy in paediatric IBD patients.
    De Ridder L; Van Dieren JM; Van Deventer HJ; Stokkers PC; Van der Woude JC; Van Vuuren AJ; Benninga MA; Escher JC; Hommes DW
    Aliment Pharmacol Ther; 2006 Apr; 23(8):1137-41. PubMed ID: 16611274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of inosine triphosphatase 94C>A and thiopurine S-methyltransferase deficiency with adverse events and study drop-outs under azathioprine therapy in a prospective Crohn disease study.
    von Ahsen N; Armstrong VW; Behrens C; von Tirpitz C; Stallmach A; Herfarth H; Stein J; Bias P; Adler G; Shipkova M; Oellerich M; Kruis W; Reinshagen M; Schütz E
    Clin Chem; 2005 Dec; 51(12):2282-8. PubMed ID: 16214825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influences of thiopurine methyltransferase genotype and activity on thiopurine-induced leukopenia in Korean patients with inflammatory bowel disease: a retrospective cohort study.
    Kim JH; Cheon JH; Hong SS; Eun CS; Byeon JS; Hong SY; Kim BY; Kwon SH; Kim SW; Han DS; Yang SK; Kim WH
    J Clin Gastroenterol; 2010; 44(10):e242-8. PubMed ID: 20308917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Prospective Study Evaluating Metabolic Capacity of Thiopurine and Associated Adverse Reactions in Japanese Patients with Inflammatory Bowel Disease (IBD).
    Odahara S; Uchiyama K; Kubota T; Ito Z; Takami S; Kobayashi H; Saito K; Koido S; Ohkusa T
    PLoS One; 2015; 10(9):e0137798. PubMed ID: 26360046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allele frequency of thiopurine methyltransferase and inosine triphosphate pyrophosphatase gene polymorphisms in Korean patients with inflammatory bowel diseases.
    Cheon JH; Kim JH; Kim BY; Kim SW; Hong SY; Eun CS; Hong SS; Byeon JS; Kim TI; Han DS; Yang SK; Lee KR; Kim WH
    Hepatogastroenterology; 2009; 56(90):421-3. PubMed ID: 19579612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inosine triphosphate pyrophosphatase 94C>A polymorphism: clinical implications for patients with systemic lupus erythematosus treated with azathioprine.
    Yamamoto K; Okada Y; Nakamura K; Hiromura K; Nojima Y; Nakamura T
    Expert Opin Drug Saf; 2010 May; 9(3):447-57. PubMed ID: 20367526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TPMT but not ITPA gene polymorphism influences the risk of azathioprine intolerance in renal transplant recipients.
    Kurzawski M; Dziewanowski K; Lener A; Drozdzik M
    Eur J Clin Pharmacol; 2009 May; 65(5):533-40. PubMed ID: 19229528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ITPA Activity in Children Treated by Azathioprine: Relationship to the Occurrence of Adverse Drug Reactions and Inflammatory Response.
    Citterio-Quentin A; Moulsma M; Gustin MP; Lachaux A; Boulieu R
    Basic Clin Pharmacol Toxicol; 2018 Jun; 122(6):588-595. PubMed ID: 29327413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meta-analysis: Inosine triphosphate pyrophosphatase polymorphisms and thiopurine toxicity in the treatment of inflammatory bowel disease.
    Van Dieren JM; Hansen BE; Kuipers EJ; Nieuwenhuis EE; Van der Woude CJ
    Aliment Pharmacol Ther; 2007 Sep; 26(5):643-52. PubMed ID: 17697198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deletion of glutathione-s-transferase m1 reduces azathioprine metabolite concentrations in young patients with inflammatory bowel disease.
    Stocco G; Cuzzoni E; De Iudicibus S; Franca R; Favretto D; Malusà N; Londero M; Cont G; Bartoli F; Martelossi S; Ventura A; Decorti G
    J Clin Gastroenterol; 2014 Jan; 48(1):43-51. PubMed ID: 23787247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.